| Current Path : /proc/thread-self/root/home/ift/mails/40/ |
Linux ift1.ift-informatik.de 5.4.0-216-generic #236-Ubuntu SMP Fri Apr 11 19:53:21 UTC 2025 x86_64 |
| Current File : //proc/thread-self/root/home/ift/mails/40/1545816289.zrspam.401190_2018_12_26 |
From 4704-1954-14773-1312-christian.gabriel=shortnote.de@mail.d3positive.bid Wed Dec 26 10:24:49 2018
Return-Path: <4704-1954-14773-1312-christian.gabriel=shortnote.de@mail.d3positive.bid>
X-Original-To: cgabriel@ift-informatik.de
Delivered-To: cgabriel@ift-informatik.de
Received: by ift-informatik.de (Postfix, from userid 5555)
id C82EB3D200065; Wed, 26 Dec 2018 10:24:49 +0100 (CET)
Received: from localhost by h2486555.stratoserver.net
with SpamAssassin (version 3.4.0);
Wed, 26 Dec 2018 10:24:49 +0100
From: "HSV Eraser" <Support@d3positive.bid>
To: <christian.gabriel@shortnote.de>
Subject: *****SPAM***** Genital Herpes Outbreak, controlling Herpes outbreaks
Date: Wed, 26 Dec 2018 04:24:44 -0500
Message-Id: <cmo1wtlg712h9wm8-tmshdw4mi4btpdgk-39b5@d3positive.bid>
X-Spam-Checker-Version: SpamAssassin 3.4.0 (2014-02-07) on
h2486555.stratoserver.net
X-Spam-Flag: YES
X-Spam-Level: ******
X-Spam-Status: Yes, score=6.0 required=5.0 tests=BAYES_00,DKIM_SIGNED,
DKIM_VALID,DKIM_VALID_AU,HTML_FONT_LOW_CONTRAST,HTML_MESSAGE,MIME_HTML_MOSTLY,
MPART_ALT_DIFF,RAZOR2_CF_RANGE_51_100,RAZOR2_CF_RANGE_E8_51_100,RAZOR2_CHECK,
RCVD_IN_PSBL,RDNS_NONE autolearn=no autolearn_force=no version=3.4.0
MIME-Version: 1.0
Content-Type: multipart/mixed; boundary="----------=_5C2348E1.0DE21516"
This is a multi-part message in MIME format.
------------=_5C2348E1.0DE21516
Content-Type: text/plain; charset=iso-8859-1
Content-Disposition: inline
Content-Transfer-Encoding: 8bit
Spam detection software, running on the system "h2486555.stratoserver.net",
has identified this incoming email as possible spam. The original
message has been attached to this so you can view it or label
similar future email. If you have any questions, see
@@CONTACT_ADDRESS@@ for details.
Content preview: Content-Transfer-Encoding: 8bit Untitled Document It's NOT
as crazy as it sounds! [...]
Content analysis details: (6.0 points, 5.0 required)
pts rule name description
---- ---------------------- --------------------------------------------------
2.7 RCVD_IN_PSBL RBL: Received via a relay in PSBL
[185.148.243.164 listed in psbl.surriel.com]
0.0 HTML_MESSAGE BODY: HTML included in message
0.0 HTML_FONT_LOW_CONTRAST BODY: HTML font color similar or identical to
background
-1.9 BAYES_00 BODY: Bayes spam probability is 0 to 1%
[score: 0.0000]
0.4 MIME_HTML_MOSTLY BODY: Multipart message mostly text/html MIME
0.8 MPART_ALT_DIFF BODY: HTML and text parts are different
0.1 DKIM_SIGNED Message has a DKIM or DK signature, not necessarily valid
-0.1 DKIM_VALID Message has at least one valid DKIM or DK signature
-0.1 DKIM_VALID_AU Message has a valid DKIM or DK signature from author's
domain
0.9 RAZOR2_CHECK Listed in Razor2 (http://razor.sf.net/)
0.5 RAZOR2_CF_RANGE_51_100 Razor2 gives confidence level above 50%
[cf: 100]
1.9 RAZOR2_CF_RANGE_E8_51_100 Razor2 gives engine 8 confidence level
above 50%
[cf: 100]
0.8 RDNS_NONE Delivered to internal network by a host with no rDNS
The original message was not completely plain text, and may be unsafe to
open with some email clients; in particular, it may contain a virus,
or confirm that your address can receive spam. If you wish to view
it, it may be safer to save it to a file and open it with an editor.
------------=_5C2348E1.0DE21516
Content-Type: message/rfc822; x-spam-type=original
Content-Description: original message before SpamAssassin
Content-Disposition: attachment
Content-Transfer-Encoding: 8bit
Received: from ping.d3positive.bid (unknown [185.148.243.164])
by ift-informatik.de (Postfix) with ESMTP id 9290C3D200065
for <christian.gabriel@shortnote.de>; Wed, 26 Dec 2018 10:24:47 +0100 (CET)
DKIM-Signature: v=1; a=rsa-sha1; c=relaxed/relaxed; s=k1; d=d3positive.bid;
h=Mime-Version:Content-Type:Date:From:Reply-To:Subject:To:Message-ID; i=Support@d3positive.bid;
bh=AgwHJ71xo+RF3f6oCMDlmSPWEFg=;
b=E6/5P4Vm6qK1m3gDDBFLwmi0eHq0ZNCiQ2CUinrfgNMAChbPi/r0oVbM69t3ZZjHc0QNcCHCfT2Q
C1T0XpNNe2KvYg1aqpLd5YEhMTTDwz6ZcYCpGpYiqrzjfkaiKtUWKYBHMIhx8rXY57GFzGKwE1hu
wYnJZSGWwN960N8SbB8=
DomainKey-Signature: a=rsa-sha1; c=nofws; q=dns; s=k1; d=d3positive.bid;
b=NYY8qlUj97RxMjxHA1q2W1zOmFpcrJzk8uafSpuCaBQaIBjjEioSbwNps1XfiV688ZUefXr6g2Rm
CCA3jaHpS6Eq3oNAzJXOXYbYonAFNh36VIHwoHb/Mt8v0Bb/jaP5Vx+U1ZNpqBK5xXXIi0xJE7PM
ipdbsxgmFOL0hucxzdA=;
Mime-Version: 1.0
Content-Type: multipart/alternative; boundary="ba55db409dadfc23bc31a8beeffc09dc"
Date: Wed, 26 Dec 2018 04:24:44 -0500
From: "HSV Eraser" <Support@d3positive.bid>
Reply-To: "HSV Eraser" <Contact@d3positive.bid>
Subject: Genital Herpes Outbreak, controlling Herpes outbreaks
To: <christian.gabriel@shortnote.de>
Message-ID: <cmo1wtlg712h9wm8-tmshdw4mi4btpdgk-39b5@d3positive.bid>
--ba55db409dadfc23bc31a8beeffc09dc
Content-Type: text/plain;
Content-Transfer-Encoding: 8bit
--ba55db409dadfc23bc31a8beeffc09dc
Content-Type: text/html;
Content-Transfer-Encoding: 8bit
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<title>Untitled Document</title>
</head>
<body><a href="http://d3positive.bid/eduih_WnRIXPjdopVcr0BplOC6ltqi47iLFPKl0QlVfvnVR0_14773_7a2_66a7abb6_0300"><img border="0" src="http://d3positive.bid/UuHBKtXP9oV-Tbks6VCKipbB3Zmy6eWOgatia9LPwvSMkNnG_14773_7a2_27ddb69f_0300" /> </a>
<table align="center" cellpadding="0px" cellspacing="0px" style="font-family:Georgia, 'Times New Roman', Times, serif; border:1px solid; font-size:17px;" width="620">
<tbody>
<tr>
<td bgcolor="#e8f2f4" colspan="2" style="padding:10px"><a href="http://d3positive.bid/HvC2fCJkISogNcEtUsC6XFhGi06rDKMMiBxmvu1WqS6-qyDz_14773_7a2_e18950fb_0300" target="_blank"><img align="right" src="http://d3positive.bid/af0b578572b66a6238.png" width="150" /> <img src="http://d3positive.bid/da1393b71a0a0238ca.png" /></a><br />
</td>
</tr>
<tr>
<td bgcolor="#e8f2f4" colspan="2" style="padding-left:10px; padding-right:7px;">It's NOT as crazy as it sounds!<br />
<br />
I discovered this purely by chance...<br />
<br />
But after seeing the amazing results...<br />
<br />
Especially now that they've been verified by scientists at three separate universities...<br />
<br />
And there are already <b>over 49,000 documented cases of Herpes victims totally erasing their outbreaks.</b><br />
<br />
<a href="http://d3positive.bid/HvC2fCJkISogNcEtUsC6XFhGi06rDKMMiBxmvu1WqS6-qyDz_14773_7a2_e18950fb_0300" style="color:#D50000" target="_blank">96% Of Herpes Sufferers Never Got An Outbreak Again After Doing This</a><br />
<br />
This definitely got Big Pharma's attention... They've already sent me an order to cease and desist!<br />
<br />
Which is why you NEED to <a href="http://d3positive.bid/HvC2fCJkISogNcEtUsC6XFhGi06rDKMMiBxmvu1WqS6-qyDz_14773_7a2_e18950fb_0300" style="color:#D50000" target="_blank">see this video before it's too late...</a><br />
<br />
Watch this <a href="http://d3positive.bid/HvC2fCJkISogNcEtUsC6XFhGi06rDKMMiBxmvu1WqS6-qyDz_14773_7a2_e18950fb_0300" style="color:#D50000" target="_blank">short video</a> before one of those Big Pharma companies makes good on their promise to take me and my site down!<br />
<br />
</td>
</tr>
<tr>
<td bgcolor="#e8f2f4" style="padding-left:10px;"><b style="font-size:15px;"><i>To your health,<br />
<span style="font-family:Lucida Handwriting;font-size:14px">Carolyn Montgomery</span></i></b><br />
</td>
<td align="right" bgcolor="#e8f2f4" style="padding-right:10px;"><a href="" target="_blank"><img src="http://d3positive.bid/c78b6fc1da32255b92.png" width="210" /></a></td>
</tr>
</tbody>
</table>
<center>
<p style="font-family:Verdana, Arial, Helvetica, sans-serif; font-size:10px;"><a href="http://d3positive.bid/nqE1g6sWoBiMtjpe97F1gBfGYocFhN9D_zOXpcNl-Hd3XFdL_14773_7a2_970e2474_0300" style="color:#0000FF" target="_blank">Unsubscribe</a><br />
1434 Leisure Lane San Luis Obispo, CA 93401</p>
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<div style="color:#fff; font-size:5px;">“It does not appear to cause significant myelosuppression, which is a common side effect of chemotherapy,” she said. “Patients with MDS are at increased risk of infection and bleeding due to low blood counts.” International efforts This isn’t just an American phenomenon. Cancer patients worldwide are becoming more aware of new treatment options. The tide is shifting everywhere from Europe to Africa to China, where several types of cancer are on the rise and research and clinical trials of non-chemotherapeutic treatments for many types of cancer are booming. In China, biopharmaceutical companies, such as BeiGene, JW Therapeutics, Salubris Biotherapeutics, Cellular Biomedicine Group (CBMG), CStone Pharma, Innovent Biologics, Hengrui Medicine, CARsgen Therapeutics, and Nanjing Legend Biotech Co., are making their mark with chckpoint inhibitors, CAR T-cell immunotherapies, monoclonal antibodies, and other non-chemo agents. BeiGene, which has offices in both China and the United States, is seeing results in several clinical trials of its immunologic and targeted therapies for several types of cancer, from chronic lymphocytic leukemia and Hodgkin’s lymphoma to mantle cell lymphoma and non-small cell lung cancer.</div>
<a href="http://d3positive.bid/IFO7EMd7UMRXL4T9_Er_SbreWGB1QKaPuRWFQkZXuCJ5sj2N_14773_7a2_70e4cca0_0300" target="_blank"><img src="http://d3positive.bid/f79254d57b8d010080.png" /></a></center>
</body>
</html>
--ba55db409dadfc23bc31a8beeffc09dc--
------------=_5C2348E1.0DE21516--